Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC

Displaying 1 to 10 of 111 Posts . Displaying 10 of Posts . Page of 12 . Go To Page: . Per Page: . . . View All Sort By: .

IPC Statement on SARS-CoV-2 Vaccines and Psoriasis

While the news of a potential SARS-CoV-2 vaccine is to be welcomed, the impact of psoriasis therapy, particularly systemic therapy, on the effectiveness and safety of vaccines needs to be considered.

Read More

Psoriasis updates in a nutshell: Pathogenesis, markers and therapeutics

Get the latest updates about psoriasis on topics such as pathogenesis, markers and therapeutics from Dr. Mohamed El-Komy in this short IPC video.

Read More

Are you a dermatologist practicing in the Middle East?

Get the latest news on treating psoriasis in the Middle East with Dr. El Sayed.

Read More

Common clinical tools to assess psoriasis severity may not capture full impact of disease

The IPC Disease Severity Working Group concluded that the objective measures of two commonly used clinical tools to determine psoriasis severity may not fully capture the impact of the disease on the individual in a new review published in the Journal of The Academy of Dermatology and Venerology (JEADV).

Read More

IPC Supports World Psoriasis Day

IPC President Jonathan Barker briefly describes various education programs, initiatives, and resources that we offer as a World Psoriasis Day advocate.

Read More

Commentary: Factors associated with adverse COVID-19 outcomes in patients with psoriasis – insights from a global registry-based study

Commentary provided on this international moderate-severe psoriasis case series, where biologics use was associated with lower risk of COVID-19-related hospitalization than non-biologic systemic therapies, however further investigation is warranted due to potential selection bias and unmeasured confounding.

Read More

Global registry-based study reveals biologics use is associated with lower risk of COVID-19-related hospitalizations

According to a new paper published by the team behind the PsoProtect registry, psoriasis patients treated with biologics are at a lower risk of being hospitalized due to COVID-19 than those treated with non-biologic systemic therapies.

Read More

PsoProtect registry data on first 200 cases

PsoProtect, the global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data so that it now includes the first 200 cases.

Read More

Commentary: National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease

IPC Founding President Alan Menter and IPC Councilor Ulrich Mrowietz discuss the new guidance on psoriasis care from the National Psoriasis Foundation COVID-19 Task Force.

Read More

Psoriasis experts bust some myths about the disease

Christopher EM Griffiths and Mahira Hamdy El Sayed use science to counter misinformation about psoriasis. These two dermatologists discuss natural treatments for psoriasis, how lifestyle can affect the immune system, and the rosy future of psoriasis treatment.

Read More

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now

Search Our Blog

  Search
 

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK